Abstract: Acyclic terpene compounds useful as intermediates for producing sarcophytol A which have an anti-carcinogenic promotor activity and anti-tumor activity, which compounds are shown by the general formula (I): ##STR1##
Abstract: A nitrogen-containing perfluoroalkanoyl peroxide is provided which is represented by the formula: ##STR1## wherein Rf.sub.1 and Rf.sub.2 independently stand for an alkyl group of 1 to 5 carbon atoms, provided that Rf.sub.1 and Rf.sub.2 are joined to each other in one of the three patterns of union, 1) direct union, 2) union through the medium of an oxygen atom or 3) union through the medium of a nitrogen atom to form one of the three rings, i.e. five-membered ring, six-membered ring or seven-membered ring.
Type:
Grant
Filed:
June 21, 1993
Date of Patent:
September 13, 1994
Assignees:
Agency of Industrial Science & Technology, Ministry of International Trade & Industry
Abstract: Four bicyclic terpenes isolated from a culture broth of Phoma sp SCF0592, ATCC 74077, pharmaceutical compositions containing them and their use as PAF antagonists to treat allergic and inflammatory diseases are disclosed.
Type:
Grant
Filed:
September 30, 1992
Date of Patent:
August 16, 1994
Assignee:
Schering Corporation
Inventors:
Min Chu, Mahesh Patel, Ann C. Horan, Vincent P. Gullo
Abstract: The invention relates to monomeric or polymeric organic compounds having non-linear optical properties, to their production and to their use as electrooptical, photorefractive or holographic devices, especially as modulators, switches, amplifiers, wave guides, sensors to work as sequence transformation especially frequency doubling. These compounds are compounds of Formula I: ##STR1## in which R.sub.1 is a group for formula a ##STR2## or R.sub.1 is a group of formula b ##STR3## or R.sub.1 is an NO.sub.2 where R.sub.1`-R.sub.11 are organic radicals.
Abstract: Azo dyes of the formula ##STR1## where A and B are each independently of the other substituted or unsubstituted phenyl or naphthyl and X is --N(R.sub.1)--SO.sub.2 --, --O--SO.sub.2 -- or --SO.sub.2 --N(R.sub.1)--, where R.sub.1 is hydrogen or C.sub.1 -C.sub.8 alkyl, produce very fast dyeings on nitrogen-containing or hydroxyl-containing fibre materials, paper or leather.
Abstract: The invention relates to a process for increasing the dyeability of textile fibers and fabrics without the need to use a salt in the dyebath. The dyeing is performed on fibers or fabrics which have been treated with potassium hydroxide and an epoxy ammonium salt of the formula: ##STR1## wherein R, R', R", and R'" are alkyl radicals having 1 to 8 carbon atoms, and X.sup.- is an anionic group selected from the group consisting of sulfate, sulfonate and halide.
Type:
Grant
Filed:
December 15, 1992
Date of Patent:
July 19, 1994
Assignee:
American Emulsions, Co.
Inventors:
David M. Hall, Tony M. Leonard, Charles D. Cofield, Hugh W. Barrow
Abstract: This invention relates to novel chiral 1,4-diol cyclic sulfates and their use as precursors in the preparation of chiral phospholane ligands, and chiral complexes useful as catalysts for carrying out enantioselective reactions.
Abstract: The present invention is a reformation process using a compact, plate-fin heat exchanger with multi-stream, multi-passage capability to provide parallel juxtaposed heat exchange of the various process streams of a reformation process.
Type:
Grant
Filed:
June 10, 1993
Date of Patent:
June 28, 1994
Assignee:
Air Products and Chemicals, Inc.
Inventors:
Rodney J. Allam, John D. Bassett, Joseph M. Abrardo, Philip L. Da Prato
Abstract: This invention provides certain 1,2,4,5 substituted benzene derivatives containing "acid" substituents derived from cyclic or heterocyclic moieties. These unique compounds are leukotriene B.sub.4 antagonists and formulations of these derivatives, and a method of using these derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
Type:
Grant
Filed:
December 10, 1992
Date of Patent:
June 28, 1994
Assignee:
Eli Lilly and Company
Inventors:
Robert D. Dillard, J. Scott Sawyer, Michael J. Sofia
Abstract: Nonlinearly optically active monomer species comprising at least two carbon-carbon activated double bonds, i.e., the polymerization of which is facilitated by the presence of an electron attracting function, and a non-centrosymmetric system of pi (.pi.
Abstract: Acyclic terpene compounds useful as intermediates or producing sarcophytol A which have an anti-carcinogenic promotor activity and anti-tumor activity, which compounds are shown by the general formula (I): ##STR1##
Abstract: The present invention is concerned with methods for the treatment of medical conditions with benzindene prostaglandins. Medical conditions which may be treated by the methods of the present invention include transplant rejection and atherosclerosis.
Abstract: Aminomethyl-chromans are obtained by alkylation of correspondingly substituted amines or by reductive amination of correspondingly substituted aldehydes. The aminomethyl-chromans can be used as active compounds in medicaments, in particular for the treatment of diseases of the central nervous system.
Type:
Grant
Filed:
October 19, 1992
Date of Patent:
June 7, 1994
Assignee:
Bayer Aktiengesellschaft
Inventors:
Rudolf Schohe-Loop, Hans-Georg Heine, Bodo Junge, Thomas Glaser, Jean M. Viktor De Vry, Wolfgang Dompert, Henning Sommermeyer
Abstract: The substituted pentaalkylchromans of the general formula: ##STR1## wherein R denotes a lower alkyl group having 1 to 4 C atoms and Hal denotes chlorine, bromine or iodine, are novel intermediates for the preparation of hypolipidaemic pharmaceuticals. A process for their preparation is described in which a trialkylhydroquinone is reacted with a halogenated butenol to give a substituted tetraalkylhydroquinone, which is finally cyclized to the final product.
Abstract: An FCC reactor achieves greater utilization of the space within the reactor vessel by using a vented riser arrangement having an inlet opening at the bottom of a vented riser collector. The inlet opening at the bottom of the vented riser collector allows plug flow of the catalyst and hydrocarbon vapors through the upper and lower section of the reactor vessel without any substantial degradation and separation efficiency between the catalyst and the hydrocarbon vapors. This permits almost the entire tangent length of the reactor vessel to be used for the purpose of catalyst and hydrocarbon contact.
Abstract: Acyclic terpene compounds useful as intermediates for producing sarcophytol A which have an anti-carcinogenic promotor activity and anti-tumor activity, which compounds are shown by the general formula (I): ##STR1##
Abstract: A new process for the preparation of 5-substituted 2-chloropyridines of the general formula (I) ##STR1## is provided, in which R represents alkyl or arylalkyl, each of which is optionally substituted by halogen.The new process is characterised in that acetenamides of the general formula (II) ##STR2## in which R has the abovementioned meaning, andR.sup.1 represents alkyl or arylalkyl, each of which is optionally substituted by halogen,are reacted with a chlorinating agent in the presence of dimethylformamide and optionally in the presence of a diluent at temperatures between -30.degree. C. and +150.degree. C.The compounds (I) prepared according to the invention may be used inter alia as intermediates for the preparation of highly efficient insecticides.
Abstract: Compounds characterized generally as piperidinyl-terminated alkylamino ethynyl alanine amino diol derivatives are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are those of Formula I ##STR1## wherein A is selected from CO and SO.sub.2 ; wherein X is selected from oxygen atom and methylene; wherein B is selected from a piperidinyl group, an isoindolyl group and an azabicyclononyl group; wherein R.sub.1 is selected from hydrido, methyl, ethyl, isopropyl and n-propyl; wherein R.sub.2 is phenylmethyl; wherein each of R.sub.3 and R.sub.5 is hydrido; wherein R.sub.4 is selected from ##STR2## wherein V is selected from hydrido and methyl; wherein R.sub.6 is cyclohexylmethyl; wherein R.sub.7 is selected from isobutyl, cyclopropyl and cyclopropylmethyl; wherein q is a number selected from zero through three, inclusive; and wherein n is a number selected from zero through three, inclusive; or a pharmaceutically-acceptable salt thereof.
Abstract: A process is disclosed for treating aramid fibers with a dispersion of particulate material in a swelling solvent to yield embodiment of the particles in the surface of the fibers.